BioServe Selected for Genetic Study on Thoracic Aortic Disease
June 18, 2007 – BioServe today announced that it has been selected by Houston-based Specialized Clinical Center of Research (SCCOR) for a novel study aimed at identifying the genetic cause of thoracic aortic disease, in which the company will provide SCCOR researchers with access to unique sample sets from its Global Repository of over 600,000 human DNA, tissue and serum samples linked to detailed clinical and demographic data to assist in identifying genes that are predictive of the development and progression of thoracic aortic diseases.
SCCOR is a collaborative program by University of Texas Health Science Center Houston, Baylor College of Medicine and University of Texas Medical Branch leading a study to define DNA sequence variants in target genes and their interacting environmental risk factors responsible for a significant proportion of the thoracic aortic diseases.
“By identifying the underlying and specific genetic causes of thoracic aortic disease we will provide doctors with the ability to predict which patients are at higher risk of aortic rupture, and treat them earlier,” said Xin Li Wang, a professor and director in the cardiothoracic research laboratory in the division of cardiothoracic surgery of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine.
For more information: www.bioserve.com
More like this
- BioNanomatrix Gets NIH Grant for Single-Molecule DNA Mapping
- BioServe, Phenomenome Develop New Colorectal Cancer Diagnostic Test
- Some Deadly Breast Cancers Share Genetic Features with Ovarian Tumors
- University of Maryland Medical Center Launches Genetic-Testing Program For Cardiac Stent Patients